About Rejuvenate Bio
Rejuvenate Bio is a private company based in San Diego, California. It has reported $34,046,354 raised in two offerings on Form D since April 2021. Its chief executive is Daniel Oliver.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 18, 2026 | $19,471,354of $27.0M target | 35 | $556K | EquityRule 506(b) | Form D ↗ |
| Apr 16, 2021 | Apr 27, 2021 | $14,575,000of $15.2M target | 22 | $662K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $34,046,354 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Rejuvenate Bio's Form D filed Jun 18, 2026.
Sources
- SECRejuvenate Bio Inc filing history
- CompanyTerms and conditions
- CompanyTeam